ONYA THERAPEUTICS LIMITED

12443293
Active Ebbw Vale

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

ONYA THERAPEUTICS LIMITED

12443293

Research and experimental development on biotechnology

Founded 5 Feb 2020 Active Ebbw Vale, United Kingdom 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation
Net assets £-1M £67K 2024 year on year
Total assets £311K £141K 2024 year on year
Total Liabilities £1M £208K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Innovation Centre Festival Drive Ebbw Vale NP23 8XA United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for ONYA THERAPEUTICS LIMITED (12443293), an active life sciences and medical technology company based in Ebbw Vale, United Kingdom. Incorporated 5 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£190.87k

Increased by £149.37k (+360%)

Net Assets

-£1.10M

Decreased by £67.16k (-7%)

Total Liabilities

£1.41M

Increased by £208.32k (+17%)

Turnover

N/A

Employees

7

Debt Ratio

453%

Decreased by 254 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2025Seed
Investor 2Jan 2025Seed

Share Capital

Share Capital

Share allotments and capital structure

143 Allotments 11,933,506 Shares £26.88m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Mar 2026268,643£19k£19k
30 Mar 2026268,643£19k£19k
27 Mar 20265,372£19k£19k
27 Mar 20265,372£19k£19k
11 Feb 20265,372£186k£186k

Officers

Officers

3 active
Status
Hafner, Thomas ChristianDirectorGermanUnited Kingdom625 Feb 2020Active
Marron, Damian JohnDirectorBritishFrance631 Dec 2022Active
Pigg, William, DrDirectorBritishEngland6410 Aug 2020Active

Shareholders

Shareholders (28)

Timothy Hafner
32.9%
1,075,453
Lucas Maximilian Hafner
32.9%
1,075,452

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Mr Timothy Calvin Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB February 1999
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr Lucas Maximilian Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB January 2001
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Neem Biotech Ltd

Ceased 1 Jan 2022

Ceased

Ctl Familienstiftung

Ceased 17 Nov 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026MiscellaneousReplacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608
4 Jun 2026MiscellaneousReplacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526
2 Jun 2026MiscellaneousReplacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54
1 Jun 2026MiscellaneousReplacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526
1 Jun 2026MiscellaneousReplacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5
4 Jun 2026 Miscellaneous

Replacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608

4 Jun 2026 Miscellaneous

Replacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526

2 Jun 2026 Miscellaneous

Replacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54

1 Jun 2026 Miscellaneous

Replacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526

1 Jun 2026 Miscellaneous

Replacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5

Recent Activity

Latest Activity

Replacement filing of SH01 - 30/03/26 Statement of Capital gbp 7.103608

2 weeks ago on 4 Jun 2026

Replacement filing of SH01 - 27/03/26 Statement of Capital gbp 6.559526

2 weeks ago on 4 Jun 2026

Replacement filing of SH01 - 31/12/25 Statement of Capital gbp 6.54

2 weeks ago on 2 Jun 2026

Replacement filing of SH01 - 11/02/26 Statement of Capital gbp 6.549526

2 weeks ago on 1 Jun 2026

Replacement filing of SH01 - 07/01/26 Statement of Capital gbp 6.5

2 weeks ago on 1 Jun 2026